Matthew E. Burow

17.9k total citations
200 papers, 9.0k citations indexed

About

Matthew E. Burow is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Matthew E. Burow has authored 200 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Molecular Biology, 74 papers in Oncology and 44 papers in Cancer Research. Recurrent topics in Matthew E. Burow's work include Cancer Cells and Metastasis (41 papers), Estrogen and related hormone effects (36 papers) and Phytoestrogen effects and research (24 papers). Matthew E. Burow is often cited by papers focused on Cancer Cells and Metastasis (41 papers), Estrogen and related hormone effects (36 papers) and Phytoestrogen effects and research (24 papers). Matthew E. Burow collaborates with scholars based in United States, China and United Kingdom. Matthew E. Burow's co-authors include John A. McLachlan, Barbara S. Beckman, Bridgette M. Collins‐Burow, Steven Elliott, Lyndsay V. Rhodes, Christopher B. Weldon, Bruce A. Bunnell, Stephen M. Boué, Amy L. Strong and Kenneth P. Nephew and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Matthew E. Burow

191 papers receiving 8.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew E. Burow United States	53	4.7k	2.1k	1.8k	1.0k	891	200	9.0k
Kyung‐Sun Kang South Korea	61	5.5k 1.2×	1.2k 0.6×	1.6k 0.9×	754 0.7×	730 0.8×	347	12.3k
Mehmet Öztürk Türkiye	45	4.1k 0.9×	2.8k 1.3×	1.4k 0.8×	635 0.6×	695 0.8×	200	8.5k
Harry van Steeg Netherlands	49	6.3k 1.4×	1.4k 0.7×	1.9k 1.0×	884 0.9×	365 0.4×	172	9.8k
Janusz Błasiak Poland	53	5.3k 1.1×	1.1k 0.5×	1.7k 0.9×	508 0.5×	722 0.8×	335	11.0k
Hong Sun United States	46	7.5k 1.6×	1.5k 0.7×	1.3k 0.7×	513 0.5×	482 0.5×	125	10.0k
Zdenko Herceg France	50	5.3k 1.1×	1.8k 0.8×	1.6k 0.9×	693 0.7×	345 0.4×	173	8.0k
Bo Xu China	44	5.8k 1.3×	2.1k 1.0×	1.8k 1.0×	980 1.0×	298 0.3×	224	8.2k
Alicja Józkowicz Poland	55	7.8k 1.7×	718 0.3×	2.2k 1.2×	917 0.9×	936 1.1×	237	12.4k
Kyung‐Chul Choi South Korea	48	3.0k 0.7×	1.2k 0.6×	1.0k 0.6×	1.6k 1.6×	659 0.7×	271	8.4k
Shile Huang United States	55	5.3k 1.1×	1.3k 0.6×	1.1k 0.6×	336 0.3×	543 0.6×	177	9.7k

Countries citing papers authored by Matthew E. Burow

Since Specialization

Citations

This map shows the geographic impact of Matthew E. Burow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew E. Burow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew E. Burow more than expected).

Fields of papers citing papers by Matthew E. Burow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew E. Burow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew E. Burow. The network helps show where Matthew E. Burow may publish in the future.

Co-authorship network of co-authors of Matthew E. Burow

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew E. Burow. A scholar is included among the top collaborators of Matthew E. Burow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew E. Burow. Matthew E. Burow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Matossian, Margarite D., Jorge A. Belgodere, Van T. Hoang, et al.. (2025). NEK Family Kinases: Structure, Function, and Role in Disease. Biomolecules. 15(10). 1406–1406.

2.

Burk, David H., Jorge A. Belgodere, William N. Beavers, et al.. (2025). Integrative Raman Spectroscopy and Multi-Omics Analysis of Lipid and Matrix Protein Heterogeneity in Triple-Negative Breast Cancer. Chemical & Biomedical Imaging. 4(3). 366–380.

3.

Mukherjee, Debarati, Rebecca A. Previs, Muthana Al Abo, et al.. (2023). Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis. Cancer Research. 83(17). 2889–2907. 14 indexed citations

4.

Boué, Stephen M., et al.. (2023). Novel Therapeutic Combination Targets the Growth of Letrozole-Resistant Breast Cancer through Decreased Cyclin B1. Nutrients. 15(7). 1632–1632. 4 indexed citations

5.

Hamel, Katie, Bridgette M. Collins‐Burow, Matthew E. Burow, et al.. (2022). Breast Cancer-Stromal Interactions: Adipose-Derived Stromal/Stem Cell Age and Cancer Subtype Mediated Remodeling. Stem Cells and Development. 31(19-20). 604–620. 7 indexed citations

6.

Kang, Hongjun, Nathan Ungerleider, Lee Spraggon, et al.. (2022). Salt-Inducible Kinase 1 is a potential therapeutic target in Desmoplastic Small Round Cell Tumor. Oncogenesis. 11(1). 18–18. 13 indexed citations

7.

Hamel, Katie, et al.. (2021). Evaluation of Extracellular Matrix Composition to Improve Breast Cancer Modeling. Tissue Engineering Part A. 27(7-8). 500–511. 20 indexed citations

8.

Dykes, Samantha S., Christine Pampo, Matthew E. Burow, et al.. (2020). Bioprinting on Live Tissue for Investigating Cancer Cell Dynamics. Tissue Engineering Part A. 27(7-8). 438–453. 12 indexed citations

9.

Matossian, Margarite D., Steven Elliott, Khoa Nguyen, et al.. (2020). Patient-Derived Xenografts as an Innovative Surrogate Tumor Model for the Investigation of Health Disparities in Triple Negative Breast Cancer. Women s Health Reports. 1(1). 383–392. 6 indexed citations

10.

Anbalagan, Muralidharan, Yifang Zhang, Yuanjun Gao, et al.. (2017). Dual Src Kinase/Pretubulin Inhibitor KX-01, Sensitizes ERα-negative Breast Cancers to Tamoxifen through ERα Reexpression. Molecular Cancer Research. 15(11). 1491–1502. 13 indexed citations

11.

Phamduy, Theresa B., Brian C. Riggs, Amy L. Strong, et al.. (2017). Laser direct-write based fabrication of a spatially-defined, biomimetic construct as a potential model for breast cancer cell invasion into adipose tissue. Biofabrication. 9(2). 25013–25013. 40 indexed citations

12.

Rhodes, Lyndsay V., Elizabeth C. Martin, H. Chris Segar, et al.. (2015). Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer. PubMed Central. 1 indexed citations

13.

Strong, Amy L., Jason F. Ohlstein, Lyndsay V. Rhodes, et al.. (2015). Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers. Breast Cancer Research. 17(1). 112–112. 155 indexed citations

14.

Zhuang, Yan, Hong T. Nguyen, Matthew E. Burow, et al.. (2014). Elevated expression of long intergenic non‐coding RNA HOTAIR in a basal‐like variant of MCF‐7 breast cancer cells. Molecular Carcinogenesis. 54(12). 1656–1667. 33 indexed citations

15.

Strong, Amy L., Lyndsay V. Rhodes, Julie A. Semon, et al.. (2013). Obesity associated alterations in the biology of adipose stem cells mediate enhanced tumorigenesis by estrogen dependent pathways. Breast Cancer Research. 15(5). R102–R102. 95 indexed citations

16.

Zhou, Changhua, Qiu Zhong, Lyndsay V. Rhodes, et al.. (2012). Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration. Breast Cancer Research. 14(2). R45–R45. 96 indexed citations

17.

Park, Margaret A., Adly Yacoub, Hossein A. Hamed, et al.. (2011). Sorafenib Enhances Pemetrexed Cytotoxicity through an Autophagy-Dependent Mechanism in Cancer Cells. Cancer Research. 71(14). 4955–4967. 97 indexed citations

18.

Bratton, Melyssa R., Daniel E. Frigo, Katinka A. Vigh‐Conrad, et al.. (2008). Organochlorine-mediated potentiation of the general coactivator p300 through p38 mitogen-activated protein kinase. Carcinogenesis. 30(1). 106–113. 21 indexed citations

19.

Ashcroft, Gillian S., Stuart J. Mills, Ke-Jian Lei, et al.. (2003). Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor. Journal of Clinical Investigation. 111(9). 1309–1318. 251 indexed citations

20.

Ashcroft, Gillian S., Stuart J. Mills, Ke-Jian Lei, et al.. (2003). Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor. Journal of Clinical Investigation. 111(9). 1309–1318. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact